Le Lézard
Classified in: Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Healthpeak Properties Announces First Quarter 2024 Earnings Release Date and Conference Call Details


Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, is scheduled to report its first quarter 2024 financial results after the close of trading on the New York Stock Exchange on Thursday, April 25, 2024.

Healthpeak will host a conference call and webcast on Friday, April 26, 2024, at 7:00 a.m. Mountain Time (9:00 a.m. Eastern Time) to review its financial performance and operating results.

The conference call can be accessed in the following ways:

An archive of the webcast will be available on Healthpeak's website through April 25, 2025, and a telephonic replay can be accessed through May 3, 2024, by dialing (800) 770-2030 and entering conference ID number 95156.

ABOUT HEALTHPEAK PROPERTIES

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate focused on the aging population and the desire for improved health. For more information regarding Healthpeak, visit https://www.healthpeak.com/.


These press releases may also interest you

at 02:36
Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 116.8 million in the first quarter of 2024 (Q1 2023: NOK 105.9 million), and EBITDA of NOK 7.9 million (NOK -1.2 million) following positive operational developments and cost...

at 02:30
Exam season is upon on us.  As students try to cope during this pressure-cooker time, many parents are turning to reward children for their hard work not just exam success according to a survey by nimbl, the leading pocket money card and app for 6 to...

at 02:29
RefluxStoptm on path to become standard of care for acid reflux treatment Significant events in the first quarter of 2024 Submitted Premarket Approval (PMA) application for RefluxStoptm to U.S. FDA First of three modules submittedNext two modules to...

at 02:00
Galantas Gold Corporation ("Galantas" or the "Company") announces that US$60,000 of convertible debentures, as detailed in releases dated November 9, 2023 and December 20, 2023 (the "Debentures") and approved by the TSX Venture Exchange, have been...

at 02:00
Novo Holdings will acquire an approximately 60% controlling stake, alongside the two company founders who will each retain 10% and Danaher which will retain 20% of the share capital. Founded in 2017 in...

at 02:00
LIST, an ION company, today announces that it has successfully completed  the certification process to connect its FastTrade electronic trading system to the Luxembourg Stock Exchange (LuxSE). This follows the successful migration of LIST's Borsa...



News published on and distributed by: